"Novo Nordisk A/S: Wegovy pill approved in the US as first oral GLP-1 for weight management" (Press release)
doi:10.1007/s12178-025-09990-7 What is BPC-157 (5mg)
In a clinical study, neuropsychological deficiencies, including reduced intelligence quotient, impaired fine-motor function, social skill deficits, and decreased olfaction, were observed in patients with BBS (10)
More frequent thyroid monitoring (every 8-12 weeks initially) is recommended when starting Wegovy in patients taking levothyroxine
Orforglipron showed stronger effects on blood sugar control, HDL cholesterol, and systolic blood pressure, while semaglutide showed larger effects on total body weight, waist circumference, and LDL cholesterol
On the other hand, semaglutide is a GLP-1 receptor agonist, primarily targeting the GLP-1 receptor